Purpose of Review: To describe the epidemiology of opioid-use disorder in the rural United States (U.S.) as it pertains to HIV and hepatitis C transmission and treatment resources. Recent Findings: Heroin and fentanyl analogs have surpassed prescription opioids in their availability in rural opioid markets adding to HIV and hepatitis C (HCV) and overdose risks. Only 18% of rural individuals live in towns with inpatient services which are of limited quality and utility. Opioid treatment programs that provide methadone are not located in rural areas and only 3% of the primary care providers have the ability to prescribe buprenorphine. National models and resources have been established but lack implementation in rural areas leading to ongoing HIV and HCV transmission and overdose. Summary: Addressing the adverse impact of opioids in the rural U.S. will require a concerted effort to implement effective treatments according to national standards.
|Number of pages||9|
|Journal||Current HIV/AIDS Reports|
|State||Published - Aug 1 2018|
Bibliographical noteFunding Information:
Funding Dr. Korthuis time is supported by the National Institutes of Health, National Institute on Drug Abuse (UG3DA044831, UG1DA015815).
Conflict of Interest P. Todd Korthuis time is supported by the National Institutes of Health, National Institute on Drug Abuse (UG3DA044831, UG1DA015815).
© 2018, Springer Science+Business Media, LLC, part of Springer Nature.
- Hepatitis C
- Opioid treatment
- Opioid treatment programs
ASJC Scopus subject areas
- Infectious Diseases